Bone marrow-derived matrix metalloproteinase-9 is associated with fibrous adhesion formation after murine flexor tendon injury

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Loiselle, Alayna E ^a   Frisch, Benjamin J ^b   Wolenski, Matthew ^a   Jacobson, Justin A ^a   Calvi, Laura M ^b   Schwarz, Edward M ^a   Awad, Hani A ^a,c   O'Keefe, Regis J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c University of Rochester   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW DERIVED MATRIX METALLOPROTEINASE 9; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE B; GROWTH DIFFERENTIATION FACTOR 5; SMAD8 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMECHANICS; BONE MARROW ABLATION; BONE MARROW CELL; CELL MIGRATION; CELL TRANSPLANTATION; CELLULAR PARAMETERS; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; FIBROUS TISSUE ADHESION; FLEXOR TENDON INJURY; GDF5 GENE; GENE; GENE DELETION; GENE EXPRESSION; KNOCKOUT MOUSE; MOUSE; MUSCLE STRENGTH; NONHUMAN; SMAD8 GENE; TISSUE ADHESION; TISSUE REGENERATION; WILD TYPE;

ANIMALS; BONE MARROW CELLS; CELL MOVEMENT; FEMALE; FIBROSIS; GENE EXPRESSION REGULATION; MATRIX METALLOPROTEINASE 9; MICE; MICE, KNOCKOUT; TENDON INJURIES; TENSILE STRENGTH; TISSUE ADHESIONS; WOUND HEALING;

MURINAE; MUS;

EID: 84863822568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040602     Document Type: Article

References (50)

1. Beredjiklian PK, (2003) Biologic aspects of flexor tendon laceration and repair. J Bone Joint Surg Am 85-A: 539-550.
2. Lin T, (2004) Biomechanics of tendon inury and repair. Journal of Biomechanics 37: 865-877.
3. Gelberman RH, Botte MJ, Spiegelman JJ, Akeson WH, (1986) The excursion and deformation of repaired flexor tendons treated with protected early motion. J Hand Surg [Am] 11: 106-110.
4. Gelberman RH, Woo SL, Lothringer K, Akeson WH, Amiel D, (1982) Effects of early intermittent passive mobilization on healing canine flexor tendons. J Hand Surg [Am] 7: 170-175.
5. Sharma P, Maffulli N, (2005) Basic biology of tendon injury and healing. Surgeon 3: 309-316.
6. Strickland JW, (2000) Development of flexor tendon surgery: twenty-five years of progress. J Hand Surg [Am] 25: 214-235.
7. Loiselle AE, Bragdon GA, Jacobson JA, Hasslund S, Cortes ZE, et al. (2009) Remodeling of murine intrasynovial tendon adhesions following injury: MMP and neotendon gene expression. J Orthop Res 27: 833-840.
8. Bi Y, Ehirchiou D, Kilts TM, Inkson CA, Embree MC, et al. (2007) Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 13: 1219-1227.
9. Jozsa L, Kannus P, (1997) Human Tendons: Anatomy, Physiology, and Pathology. Champaign, IL.
10. Kannus P, (2000) Structure of the tendon connective tissue. Scand J Med Sci Sports 10: 312-320.
11. Woo SL, Debski RE, Zeminski J, Abramowitch SD, Saw SS, et al. (2000) Injury and repair of ligaments and tendons. Annu Rev Biomed Eng 2: 83-118.
12. Coussens LM, Tinkle CL, Hanahan D, Werb Z, (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490.
13. Heissig B, Nishida C, Tashiro Y, Sato Y, Ishihara M, et al. (2010) Role of neutrophil-derived matrix metalloproteinase-9 in tissue regeneration. Histology and histopathology 25: 765-770.
14. Karousou E, Ronga M, Vigetti D, Passi A, Maffulli N, (2008) Collagens, proteoglycans, MMP-2, MMP-9 and TIMPs in human achilles tendon rupture. Clinical orthopaedics and related research 466: 1577-1582.
15. Parkinson J, Samiric T, Ilic M, Cook J, Feller J, et al. (2010) Change in proteoglycan metabolism is a characteristic of human patellar tendinopathy. Arthritis Rheum 62: 3028-3035.
16. Voloshin I, Gelinas J, Maloney MD, O'Keefe RJ, Bigliani LU, et al. (2005) Proinflammatory cytokines and metalloproteases are expressed in the subacromial bursa in patients with rotator cuff disease. Arthroscopy 21: 1076.
17. Hsu JY, Bourguignon LY, Adams CM, Peyrollier K, Zhang H, et al. (2008) Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord. J Neurosci 28: 13467-13477.
18. Corbel M, Belleguic C, Boichot E, Lagente V, (2002) Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol 18: 51-61.
19. Busch SA, Horn KP, Silver DJ, Silver J, (2009) Overcoming macrophage-mediated axonal dieback following CNS injury. The Journal of neuroscience: the official journal of the Society for Neuroscience 29: 9967-9976.
20. Lim DH, Cho JY, Miller M, McElwain K, McElwain S, et al. (2006) Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice. American journal of physiology Lung cellular and molecular physiology 291: L265-271.
21. Mukherjee R, Colbath GP, Justus CD, Bruce JA, Allen CM, et al. (2010) Spatiotemporal induction of matrix metalloproteinase-9 transcription after discrete myocardial injury. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology 24: 3819-3828.
22. Rosenberg GA, Cunningham LA, Wallace J, Alexander S, Estrada EY, et al. (2001) Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain research 893: 104-112.
23. Scabilloni JF, Wang L, Antonini JM, Roberts JR, Castranova V, et al. (2005) Matrix metalloproteinase induction in fibrosis and fibrotic nodule formation due to silica inhalation. American journal of physiology Lung cellular and molecular physiology 288: L709-717.
24. Tan RJ, Fattman CL, Niehouse LM, Tobolewski JM, Hanford LE, et al. (2006) Matrix metalloproteinases promote inflammation and fibrosis in asbestos-induced lung injury in mice. American journal of respiratory cell and molecular biology 35: 289-297.
25. Wang L, Mercer RR, Rojanasakul Y, Qiu A, Lu Y, et al. (2010) Direct fibrogenic effects of dispersed single-walled carbon nanotubes on human lung fibroblasts. Journal of toxicology and environmental health Part A 73: 410-422.
26. Zhou J, Tang PC, Qin L, Gayed PM, Li W, et al. (2010) CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses. The Journal of experimental medicine 207: 1951-1966.
27. Gieling RG, Wallace K, Han YP, (2009) Interleukin-1 participates in the progression from liver injury to fibrosis. American journal of physiology Gastrointestinal and liver physiology 296: G1324-1331.
28. Natividad A, Cooke G, Holland MJ, Burton MJ, Joof HM, et al. (2006) A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection. BMC medical genetics 7: 40.
29. Kajikawa Y, Morihara T, Watanabe N, Sakamoto H, Matsuda K, et al. (2007) GFP chimeric models exhibited a biphasic pattern of mesenchymal cell invasion in tendon healing. J Cell Physiol 210: 684-691.
30. Kollet O, Shivtiel S, Chen YQ, Suriawinata J, Thung SN, et al. (2003) HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. The Journal of clinical investigation 112: 160-169.
31. Wang L, Luo J, He S, (2007) Induction of MMP-9 release from human dermal fibroblasts by thrombin: involvement of JAK/STAT3 signaling pathway in MMP-9 release. BMC cell biology 8: 14.
32. Warner RL, Bhagavathula N, Nerusu KC, Lateef H, Younkin E, et al. (2004) Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. Experimental and molecular pathology 76: 189-195.
33. Ingraham CA, Park GC, Makarenkova HP, Crossin KL, (2011) Matrix metalloproteinase (MMP)-9 induced by Wnt signaling increases the proliferation and migration of embryonic neural stem cells at low O2 levels. The Journal of biological chemistry.
34. Nee L, Tuite N, Ryan MP, McMorrow T, (2007) TNF-alpha and IL-1 beta-mediated regulation of MMP-9 and TIMP-1 in human glomerular mesangial cells. Nephron Experimental nephrology 107: e73-86.
35. Turner NA, Aley PK, Hall KT, Warburton P, Galloway S, et al. (2007) Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and-independent mechanisms. Journal of molecular and cellular cardiology 43: 168-176.
36. Wu CY, Hsieh HL, Sun CC, Yang CM, (2009) IL-1beta induces MMP-9 expression via a Ca2+-dependent CaMKII/JNK/c-JUN cascade in rat brain astrocytes. Glia 57: 1775-1789.
37. Xia L, Shen H, Lu J, Xiao W, (2011) TRAF2 and cIAP2 involve in TWEAK-induced MMP-9 production in fibroblast-like synoviocytes. Rheumatology international.
38. Muroski ME, Roycik MD, Newcomer RG, Van den Steen PE, Opdenakker G, et al. (2008) Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis. Current pharmaceutical biotechnology 9: 34-46.
39. Katzel EB, Wolenski M, Loiselle AE, Basile P, Flick LM, et al. (2011) Impact of Smad3 loss of function on scarring and adhesion formation during tendon healing. Journal of orthopaedic research: official publication of the Orthopaedic Research Society 29: 684-693.
40. Aslan H, Kimelman-Bleich N, Pelled G, Gazit D, (2008) Molecular targets for tendon neoformation. J Clin Invest 118: 439-444.
41. Hoffmann A, Pelled G, Turgeman G, Eberle P, Zilberman Y, et al. (2006) Neotendon formation induced by manipulation of the Smad8 signaling pathway in mesenchymal stem cells. J Clin Invest 116: 940-952.
42. Shahab-Osterloh S, Witte F, Hoffmann A, Winkel A, Laggies S, et al. (2010) Mesenchymal stem cell-dependent formation of heterotopic tendon-bone insertions (osteotendinous junctions). Stem Cells 28: 1590-1601.
43. Wolfman NM, Hattersley G, Cox K, Celeste AJ, Nelson R, et al. (1997) Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family. J Clin Invest 100: 321-330.
44. Beredjiklian PK, Favata M, Cartmell JS, Flanagan CL, Crombleholme TM, et al. (2003) Regenerative versus reparative healing in tendon: a study of biomechanical and histological properties in fetal sheep. Ann Biomed Eng 31: 1143-1152.
45. Strickland JW, (1995) Flexor Tendon Injuries: I. Foundations of Treatment. J Am Acad Orthop Surg 3: 44-54.
46. Kulick MI, Smith S, Hadler K, (1986) Oral ibuprofen: evaluation of its effect on peritendinous adhesions and the breaking strength of a tenorrhaphy. J Hand Surg Am 11: 110-120.
47. Virchenko O, Skoglund B, Aspenberg P, (2004) Parecoxib impairs early tendon repair but improves later remodeling. Am J Sports Med 32: 1743-1747.
48. Hu J, Van den Steen PE, Sang QX, Opdenakker G, (2007) Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nature reviews Drug discovery 6: 480-498.
49. Hasslund S, Jacobson JA, Dadali T, Basile P, Ulrich-Vinther M, et al. (2008) Adhesions in a murine flexor tendon graft model: autograft versus allograft reconstruction. J Orthop Res 26: 824-833.
50. Frisch BJ, Porter RL, Gigliotti BJ, Olm-Shipman AJ, Weber JM, et al. (2009) In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells. Blood 114: 4054-4063.